Stock listing
OTC:MBVX MabVax Therapeutics Holdings Inc Stock
Follow MabVax Therapeutics Holdings Inc into a list and get an email when it puts out news.
Delisted OTC:MBVX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- OTC:MBVX
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
MabVax Therapeutics Holdings Inc on 6ix
- Decks
- 17 decks · latest Oct 22, 2018
Where MabVax Therapeutics Holdings Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| OTC:MBVX · This page · Delisted | OTC | United States | USD |
| OTC:MBVXQ · Delisted | OTC | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (October 2018) | Investor deck | 19 slides | Oct 22, 2018 |
| Virtual Investor Conference (May 2018) | Conference | 25 slides | May 3, 2018 |
| Investor Presentation (February 2018) | Investor deck | 24 slides | Feb 12, 2018 |
| Investor Presentation (September 2017) | Investor deck | 33 slides | Sep 12, 2017 |
| Investor Presentation (August 2017) | Investor deck | 33 slides | Aug 24, 2017 |
| Investor Presentation (June 2017) | Investor deck | 23 slides | Jun 23, 2017 |
| Technical Presentation (April 2017) | Technical | 57 slides | Apr 7, 2017 |
| Investor Presentation (March 2017) | Investor deck | 37 slides | Mar 31, 2017 |
| Investor Presentation (March 2017) | Investor deck | 57 slides | Mar 29, 2017 |
| BIO CEO 2017 Investor Conference | Conference | 41 slides | Feb 13, 2017 |
All 17 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2016) | Investor deck | 30 slides | Dec 7, 2016 |
| Rodman Conference (September 2016) | Conference | 32 slides | Sep 13, 2016 |
| Investor Presentation (September 2016) | Investor deck | 31 slides | Sep 6, 2016 |
| Investor Presentation (June 2016) | Investor deck | 30 slides | Jun 15, 2016 |
| Investor Presentation (February 2016) | Investor deck | 30 slides | Feb 12, 2016 |
| Investor Presentation (October 2015) | Investor deck | 26 slides | Oct 22, 2015 |
| Investor Presentation (May 2015) | Investor deck | 24 slides | May 27, 2015 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert E. Hoffman Other companies: CytoDyn Inc. (Chief Executive Officer · Since at least May 15, 2025); Esperion Therapeutics, Inc. (Director · Since at least Apr 1, 2025); FibroBiologics, Inc. (Board of Directors · Since at least Jan 24, 2024); TuHURA Biosciences, Inc. (Director · Since at least Apr 11, 2018); Aravive Inc (Director · Oct 12, 2018 – Sep 12, 2019 · Past); Heron Therapeutics, Inc. (CFO & SVP, Finance · Apr 24, 2017 – Dec 19, 2019 · Past); Kura Oncology, Inc. (Director · May 12, 2016 – Jun 22, 2021 · Past); CombiMatrix Corp (Director · May 10, 2016 – Nov 14, 2017 · Past) | Director · Aug 26, 2015 – May 19, 2017 · Past |
| Jeffrey F Eisenberg Other companies: Xenetic Biosciences, Inc. (Chief Executive Officer, Director · Nov 1, 2016 – Dec 11, 2023 · Past) | Director · Feb 19, 2016 – Feb 21, 2018 · Past |
| Gregory P Hanson | CHIEF FINANCIAL OFFICER, SECR · Dec 16, 2014 – Apr 2, 2018 · Past |
| Jeffrey V Ravetch | Director · Apr 2, 2015 – Jun 12, 2017 · Past |
| Paul W Maffuid | EXEC. VP, R AND D · Dec 31, 2014 – Apr 2, 2018 · Past |
| Philip O Livingston | CHIEF SCIENCE OFFICER, Director · Apr 4, 2015 – Feb 21, 2018 · Past |
Log in to ask 6ix AI your own questions about MabVax Therapeutics Holdings Inc.